As of 2025-07-21, the EV/EBITDA ratio of Singular Genomics Systems Inc (OMIC) is -0.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OMIC's latest enterprise value is 8.34 mil USD. OMIC's TTM EBITDA according to its financial statements is -88.87 mil USD. Dividing these 2 quantities gives us the above OMIC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 16.1x | 14.0x |
| Forward P/E multiples | 15.7x - 17.3x | 16.4x |
| Fair Price | (533.38) - (548.83) | (517.22) |
| Upside | -2765.6% - -2842.8% | -2684.8% |
| Date | EV/EBITDA |
| 2025-02-20 | -0.09 |
| 2025-02-19 | -0.09 |
| 2025-02-18 | -0.09 |
| 2025-02-14 | -0.09 |
| 2025-02-13 | -0.09 |
| 2025-02-12 | -0.09 |
| 2025-02-11 | -0.09 |
| 2025-02-10 | -0.09 |
| 2025-02-07 | -0.09 |
| 2025-02-06 | -0.09 |
| 2025-02-05 | -0.09 |
| 2025-02-04 | -0.09 |
| 2025-02-03 | -0.09 |